Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronnda L Bartel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Stem Cell Research & Therapy|January 11, 2014
Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophagesKelly J Ledford, Frank Zeigler, Ronnda L Bartel
Stem Cell Research & Therapy|January 11, 2014
Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseasesKelly J Ledford, Nikki Murphy, Frank Zeigler, et al.
Stem Cell Reviews and Reports|March 5, 2013
From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-TRonnda L Bartel, Erin Booth, Caryn Cramer, et al.
Stem Cell Research & Therapy|April 19, 2015
Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseasesKelly J Ledford, Nikki Murphy, Frank Zeigler, et al.
Stem Cell Research & Therapy|July 11, 2012
The Aastrom experienceRonnda L Bartel, Caryn Cramer, Kelly Ledford, et al.
Tissue Engineering. Part A|April 24, 2010
Angiogenic and osteogenic potential of bone repair cells for craniofacial regenerationDarnell Kaigler, Giorgio Pagni, Chan-Ho Park, et al.
Cell Transplantation|July 11, 2012
Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trialDarnell Kaigler, Giorgio Pagni, Chan Ho Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2012
Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trialRichard J Powell, William A Marston, Scott A Berceli, et al.
Journal of Vascular Surgery|June 21, 2011
Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemiaRichard J Powell, Anthony J Comerota, Scott A Berceli, et al.
Circulation. Cardiovascular Interventions|January 24, 2022
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular DysfunctionTimothy D Henry, C Noel Bairey Merz, Janet Wei, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Stem Cell Research & Therapy|January 11, 2014
Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophagesKelly J Ledford, Frank Zeigler, Ronnda L Bartel
Stem Cell Research & Therapy|January 11, 2014
Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseasesKelly J Ledford, Nikki Murphy, Frank Zeigler, et al.
Stem Cell Reviews and Reports|March 5, 2013
From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-TRonnda L Bartel, Erin Booth, Caryn Cramer, et al.
Stem Cell Research & Therapy|April 19, 2015
Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseasesKelly J Ledford, Nikki Murphy, Frank Zeigler, et al.
Stem Cell Research & Therapy|July 11, 2012
The Aastrom experienceRonnda L Bartel, Caryn Cramer, Kelly Ledford, et al.
Tissue Engineering. Part A|April 24, 2010
Angiogenic and osteogenic potential of bone repair cells for craniofacial regenerationDarnell Kaigler, Giorgio Pagni, Chan-Ho Park, et al.
Cell Transplantation|July 11, 2012
Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trialDarnell Kaigler, Giorgio Pagni, Chan Ho Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2012
Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trialRichard J Powell, William A Marston, Scott A Berceli, et al.
Journal of Vascular Surgery|June 21, 2011
Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemiaRichard J Powell, Anthony J Comerota, Scott A Berceli, et al.
Circulation. Cardiovascular Interventions|January 24, 2022
Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular DysfunctionTimothy D Henry, C Noel Bairey Merz, Janet Wei, et al.
Pageof 1